TrialProstate cancer and prostatic diseases2021

Bone targeted therapy and skeletal related events in the era of enzalutamide and abiraterone acetate for castration resistant prostate cancer with bone metastases.

Bradley McGregor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.